Patients with endometriosis and patients with poor ovarian reserve have abnormal follicle-stimulating hormone receptor signaling pathways

详细信息    查看全文

• 作者：Rebeca Gonz&#xe1 ; lez-Fern&#xe1 ; ndez ; Ó ; scar Peñ ; a ; Jairo Hern&#xe1 ; ndez ; Pablo Mart&#xed ; n-Vasallo ; Angela Palumbo ; Julio Á ; vila
• 关键词：Granulosa-lutein cells ; PAPP and CYP19A1 genes ; in vitro fertilization ; FSHR pathway signaling
• 刊名：Fertility and Sterility
• 出版年：2011
• 出版时间：June 2011
• 年：2011
• 卷：95
• 期：7
• 页码：2373-2378
• 全文大小：431 K

文摘

Objective

To study the integrity of the FSH receptor (FSHR) signaling pathway in granulosa-lutein cells at the time of egg retrieval and its relationship with the infertility diagnosis.

Design

In vitro assays.

Setting

University laboratory and private IVF center.

Patient(s)

Patients undergoing IVF: 35 controls (no ovarian factor, NOF), 28 poor responders (PR), 32 patients with endometriosis (EM), and 22 patients with polycystic ovary syndrome (PCOS).

Intervention(s)

Quantitative reverse transcriptase-polymerase chain reaction (PCR) in granulosa-lutein cells from pooled follicles.

Main Outcome Measure(s)

Correlation between expression of FSHR and FSH-regulated genes PAPP/Cyp19A1.

Result(s)

Positive correlations among FSHR, PAPP, and Cyp19A1 expression levels are observed in NOF and are lost, with different patterns, in poor responder patients and those with endometriosis. Patients with endometriosis are an heterogeneous group including patients with poor ovarian reserve who behave like other poor responders patients (endometriosis-A) and patients with good response to ovarian stimulation (endometriosis-B) who show a specific alteration of the FSHR signaling pathway.

Conclusion(s)

These preliminary data suggest that the different signaling pathways activated through the FSHR in normal ovaries (NOF) are disrupted in poor responders and in patients with endometriosis. A better knowledge of the molecular origin of these errors may guide clinicians in the choice of personalized ovulation induction protocols for each type of ovarian dysfunction.